Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clavulanic acid and IV cocaine interaction study
NCT02563769Phase 1Completed
- Sponsor
- Temple University
- Start
- Oct 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of clavulanic acid in cocaine use disorder (CUD) (3 arms), sponsored by Temple University. Primary endpoints: Number of Participants With Severe Adverse Events at 6 days, Change in Heart Rate in Response to IV Cocaine Infusion With and Without CLAV Dosing at 4 days and 2 more. Started Oct 2016; status: completed.
02
Drugs
clavulanic acid
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT02563769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02563769.